Millie
your market intelligence analyst
Search Results
623 results
Your search is now limited to «Colorectal Cancer» expert search.
PR Newswire 07/18/2019 06:32
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement to investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as combination therapy in patients with metastatic colorectal cancer.
More from PR Newswire:
Bayer 07/18/2019 06:30
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement to investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as combination therapy in patients with colorectal cancer.
PharmiWeb.com 07/18/2019 06:00
The OncoBEAM RAS CRC test has an analytical sensitivity down to 0.03% MAF.
More from PharmiWeb.com:
Novel variants of unknown significance in the PMS2 gene identified in patients with hereditary colon cancer.
More from International Journal of COPD:
Targeted Oncology 07/17/2019 12:12
Regorafenib was approved for the treatment of patients with metastatic CRC whose disease had progressed after prior therapy in 2012.
More from Targeted Oncology:
Onclive 07/17/2019 11:10
Although therapies aimed at BRAF mutations have shown efficacy in several tumor types, these drugs have demonstrated limited success in studies involving patients with colorectal cancer (CRC.
More from Onclive:
News-Medical.net 07/16/2019 09:47
... study performed at the Institute for Research in Biomedicine(IRB Barcelona)and published in the journal Nature Communications demonstrates that inhibition of the p38 protein boosts the formation of blood vessels in human and mice colon cancers.
More from News-Medical.net:
ClinicalTrials.gov 07/16/2019 07:55
Population-based screening programs for breast, cervical, and colorectal cancer have been introduced as part of cancer control in many high-income countries.
More from ClinicalTrials.gov:
ecancer news 07/16/2019 06:03
That is, the participants who followed an inflammatory diet had almost twice the risk of developing colorectal cancer, which is the 4th most frequent cancer worldwide", explains Dr. Mireia Obón.
More from ecancer news:
Healio News 07/15/2019 15:21
Patients who undergo polypectomy during an initial colonoscopy screening are at higher risk for colorectal cancer, but only if the removed polyps fall into certain categories, according to study results.
More from Healio News:
Purpose:. Four consensus molecular subtypes (CMS1–4) of colorectal cancer were identified in primary tumors and found to be associated with distinctive biological features and clinical outcomes. Given that distant metastasis largely accounts for colorectal cancer–related mortality, we examined the molecular and clinical attributes of CMS in metastatic colorectal cancer (mCRC). Experimental Design:. We developed a colorectal cancer–focused NanoString-based CMS classifier that is ideally suited to interrogate archival tissues. We successfully used this panel in the CMS classification of formalin-fixed paraffin-embedded (FFPE) tissues from mCRC cohorts, one of which is composed of paired primary tumors and metastases. Finally, we developed novel.
More from Clinical Cancer Research - Recent Issues (abstracts):
Cancer Cell International 07/14/2019 20:00
Compared with traditional biomarkers such as CEA and CA19-9 which have been widely used as tumor markers for CRC in clinical settings, our results also indicated that miR-29 has superior diagnostic properties for CRC screening due to its higher sensitivity, noninvasiveness, and simple detection.
More from Cancer Cell International:
FeedNavigator (EU) 07/14/2019 08:23
No summary found
More from FeedNavigator (EU):
ETHealthWorld (India) 07/14/2019 03:12
Regorafenib is used to treat colorectal cancer, known to be the sixth most prevalent cancer in India.
More from ETHealthWorld (India):
NaturalNews.com 07/11/2019 22:12
Therefore, the Korean research team investigated the potential mechanisms of branches and leaves of the Chinese sweet plum using SW480 colorectal cancer cells, which are widely used to examine the potency of treatment in cancer prevention and treatment.
More from NaturalNews.com:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications